Get in Touch

Krishna Knabe
Director of Communications

Alzheimer's Matters Blog

CTAD 2017 Conference

ADDF Impact

CTAD Conference Highlights Our Funded Research

This Wednesday marks the beginning of National Alzheimer's Disease Awareness Month and the 10th Clinical Trials on Alzheimer's Disease conference, which features a record amount of research we have supported.

Combination Therapy

Developing Drugs

Combination Therapy: The Right Approach for Alzheimer’s

Learn why combination therapy holds such promise for treating Alzheimer's disease, and why Amylyx's drug is the first such therapy we are funding.

Howard Fillit and D. Martin Watterson

ADDF Impact

Driving Innovation in Alzheimer’s Therapies

At our 18th Annual Conference on Alzheimer’s Drug Discovery in Jersey City, the impact of our approach will take center stage.


Featured Video

Sharon Sager from UBS received The Charles Evans Award at the ADDF's Eighth Annual Fall Symposium & Luncheon. This year was the largest and most successful in the event's history, welcoming over 400 guests and raising over $1.2 million for Alzheimer's research.

View more on our YouTube channel

Fact Sheets & Publications